Cardiac Point-of-Care (POC) Market Size, Share, Industry Analysis, Trends, Growth, Forecasts, 2030

Cardiac Point-of-Care (POC) Market

Cardiac Point-of-Care (POC) Market By Device Type (cardiac POC testing analyzer and cardiac POC test kits), By further sub-divided (biomarker test, myoglobin biomarker test, myoglobin biomarker test, cardiac troponin biomarker test, hybrid test, creatine kinase-myoglobin (CK-MB), and brain natriuretic peptide (BNP) test.) And By Region: - Global and Regional Industry Overview, Market Intelligence, Comprehensive Analysis, Historical Data, and Forecasts, 2023-2030

Category: Healthcare Report Format : PDF Report Code: ZMR-2953 Status : Upcoming
Market Size in 2022 Market Forecast in 2030 Growth Rate (in %) Base Year
USD 1,680.70 Million USD 3,608.90 Million CAGR at 10.02% 2022

Cardiac Point-of-Care (POC) Market

Description

According to the report published by Zion Market Research, the global Cardiac Point-of-Care (POC) Market size was valued at USD 1,680.70 Million in 2022 and is predicted to reach USD 3,608.90 Million by the end of 2030. The market is expected to grow with a CAGR of 10.02% during the forecast period. The report analyzes the global Cardiac Point-of-Care (POC) Market’s growth drivers, restraints, and impact on demand during the forecast period. It will also help navigate and explore the arising opportunities in the Cardiac Point-of-Care (POC) Market industry.

Global Cardiac Point-of-Care (POC) Market SizeRequest Free Sample

Global Cardiac Point-of-Care (POC) Market: Overview

Cardiac POC is a type of blood test which also includes testing of the cholesterol and coagulation. Cardiac POC helps in the detection of the enzyme that is released if a person is suffering from critical cardiac illness. Enzymes can be lactate, brain natriuretic peptides, troponin, and dehydrogenase isoenzymes. Cardiac POCs are also helpful in detecting other conditions such as angina and myocardial infarction. The cardiac POC provides precise information about the markers that are released when the heart fails. Owing to the test the turnaround time minimizes thus helping in early diagnosis.

Global Cardiac Point-of-Care (POC) Market: Growth Factors

Some of the factors that are driving the growth of the cardiac point-of-care (POC) market are the growing numbers of the cardiac patients and the increasing requirement to diagnose these diseases. Moreover, the decrease in the turnaround time and availability of the technically advanced products having enhanced characteristics such as automation and miniaturization is also propelling the growth of the market.

Factors that are limiting the growth of the cardiac point-of-care (POC) market are a financial downturn and the concerns regarding reimbursement. One of the challenges faced by the market is the lack of precise actions in detecting the existence of the cardiovascular diseases.

The introduction of the novel products, mergers and acquisitions by the market players, and the increasing diagnostic facilities are some of the trends that are positively affecting the growth of the market.

Cardiac Point-of-Care (POC) MarketRequest Free Sample

Global Cardiac Point-of-Care (POC) Market: Segmentation

The cardiac point-of-care (POC) market is segmented based on the device type.

On the basis of the device type, the market is segregated into cardiac POC testing analyzer and cardiac POC test kits. The cardiac POC test kits are further sub-divided into biomarker test, myoglobin biomarker test, myoglobin biomarker test, cardiac troponin biomarker test, hybrid test, creatine kinase-myoglobin (CK-MB), and brain natriuretic peptide (BNP) test.

Cardiac Point-of-Care (POC) Market: Report Scope

Report Attributes Report Details
Report Name Cardiac Point-of-Care (POC) Market Research Report
Market Size in 2022 USD 1,680.70 Million
Market Forecast in 2030 USD 3,608.90 Million
Growth Rate CAGR of 10.02%
Number of Pages 180
Key Companies Covered Alere Inc., Boston Scientific Corp., Abbott Laboratories, Roche Diagnostics, and Medtronic Inc., among others.
Segments Covered By Device Type, By further sub-divided, By Region
Regions Covered North America, Europe, Asia Pacific (APAC), Latin America, Middle East, and Africa (MEA)
Base Year 2022
Historical Year 2017 to 2021
Forecast Year 2023 - 2030
Customization Scope Avail customized purchase options to meet your exact research needs. Request For Customization

Global Cardiac Point-of-Care (POC) Market: Regional Analysis

North America is dominating the cardiac point-of-care (POC) market which is followed by Europe. The major factors that are driving the market are the growing demand for the home healthcare, increased number of cardiac patients, and the favorable government policies. Other factors that are positively influencing the market growth are favorable healthcare reforms, early adoption of the advanced technologies, advanced healthcare infrastructure, a wide range of upgradation in the Clinical Laboratory Improvement Amendments (CLIA) waved measures and the increased health awareness among the patients. The cardiac point-of-care (POC) market in Europe is positively affected due to the increased occurrences of chronic ailments, improved focus in the advancement of the connected healthcare, and the growing demand for the POC testing devices.

The cardiac point-of-care (POC) market in the Asia Pacific is expected to develop at a rapid rate in the coming years owing to the increasing healthcare spending and the growing awareness about the diagnostic treatments.

Global Cardiac Point-of-Care (POC) Market: Competitive Players

Some of the most important market players in the cardiac point-of-care (POC) market include :

  • Alere Inc.
  • Boston Scientific Corp.
  • Abbott Laboratories
  • Roche Diagnostics
  • Medtronic Inc.,
  • among others.

The global Cardiac Point-of-Care (POC) Market is segmented as follows:

By Device Type 

  • cardiac POC testing analyzer and 
  • cardiac POC test kits

By further sub-divided 

  • biomarker test
  • myoglobin biomarker test
  • myoglobin biomarker test 
  • cardiac troponin biomarker test
  • hybrid test 
  • creatine kinase-myoglobin (CK-MB) 
  • and brain natriuretic peptide (BNP) test

Global Cardiac Point-of-Care (POC) Market: Regional Segment Analysis

  • North America
    • The U.S.
  • Europe
    • The UK
    • France
    • Germany
  • The Asia Pacific
    • China
    • Japan
    • India
  • Latin America
    • Brazil
  • The Middle East and Africa

What Reports Provides

  • Full in-depth analysis of the parent market
  • Important changes in market dynamics
  • Segmentation details of the market
  • Former, on-going, and projected market analysis in terms of volume and value
  • Assessment of niche industry developments
  • Market share analysis
  • Key strategies of major players
  • Emerging segments and regional markets
  • Testimonials to companies in order to fortify their foothold in the market.

Table Of Content

  • zion payment modes

FrequentlyAsked Questions

Cardiac Point-of-Care (POC) refers to rapid diagnostic testing performed near the patient to detect cardiac biomarkers. It enables quick diagnosis and timely management of heart-related conditions.
The global cardiac point-of-care (POC) market is expected to be driven by the rising cardiovascular disease prevalence, demand for rapid diagnostics, and increasing use of bedside and emergency testing.
According to study, the global cardiac point-of-care (POC) market size was worth around USD 1,680.70 Million in 2022 and is predicted to grow to around USD 3,608.90 Million by 2030.
The global cardiac point-of-care (POC) market is expected to grow at a Compound Annual Growth Rate (CAGR) of around CAGR 10.02% during the forecast period from 2023-2030.
The global cardiac point-of-care (POC) industry is projected to be challenged by Challenges include strict clinical validation, accuracy requirements, and regulatory approvals. Reimbursement uncertainty and integration into emergency workflows affect adoption rates.
The Opportunities include rapid diagnostics in emergency and remote settings, decentralized healthcare, and integration with digital health platforms. Aging populations drive demand will offer significant growth opportunities in the cardiac point-of-care (POC) market.
AI-assisted cardiac biomarker detection; microfluidic & lab-on-chip platforms; connectivity to EMR for fast triage are the emerging trends and innovations impacting the cardiac point-of-care (POC) market.
The global cardiac point-of-care (POC) market is expected to be led by North America during the forecast period.
Some of the prominent players operating in the global cardiac point-of-care (POC) market are; Alere Inc., Boston Scientific Corp., Abbott Laboratories, Roche Diagnostics, and Medtronic Inc., among others. and others.
The report explores crucial aspects of the cardiac point-of-care (POC) market, including a detailed discussion of existing growth factors and restraints, while also browsing future growth opportunities and challenges that impact the market.

HappyClients

Office Address

Contact Us

Zion Market Research
Tel: +1 (302) 444-0166
USA/Canada Toll Free No.+1 (855) 465-4651

Asia Pacific Office

3rd Floor, Mrunal Paradise, Opp Maharaja Hotel, Pimple Gurav, Pune 411061, Maharashtra, India
Phone No +91 7768 006 007, +91 7768 006 008

Contact #

US OFFICE NO +1 (302) 444-0166
US/CAN TOLL FREE +1 (855) 465-4651
Email: sales@zionmarketresearch.com

We Are On Social

We Accept

We have secured system to process your transaction.

  • payment methods

Business Hours

Our support available to help you 24 hours a day, five days a week.

Monday - Friday: 9AM - 6PM

Saturday - Sunday: Closed